Wichniak, A.; Brunner, H.; Ising, M.; Gil, F. P.; Holsboer, F.; Friess, E.: Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression. Psychoneuroendocrinology 29 (9), S. 1101 - 1108 (2004)

Zhang, Z. W.; Hofmann, C.; Casanova, E.; Schutz, G.; Lutz, B.: Generation of a conditional allele of the CBP gene in mouse. Genesis 40 (2), S. 82 - 89 (2004)

Barden, N.; Harvey, M.; Shink, E.; Tremblay, M.; Gagne, B.; Raymond, C.; Labbe, M.; St Onge, L.; Stadler, H.; Sillaber, I. et al.; Paez-Pereda, M.; Müller-Myhsok, B.; Binder, E.; Holsboer, F.: Identification and characterisation of a gene predisposing to both bipolar and unipolar afective disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 122 - 122 (2004)

Binder, E. B.; Salyakina, D.; Wochnik, G.; Ising, M.; Pütz, B.; Kern, N.; Lucae, S.; Mueller, J. C.; Lohmussaar, E.; Meitinger, T. et al.; Baghai, T.; Bondy, B.; Rupprecht, R.; Uhr, M.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: Polymorphisms in FKBP5, a co-chaperone of the glucocorticoid receptor are associated with response to antidepressant drugs. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 13 - 13 (2004)

Cichon, S.; Schumacher, J.; Abou Jamra, R.; Becker, T.; Ohlraun, S.; Klopp, N.; Binder, E.; Schulze, T. G.; Maier, W.; Van den Bogaert, A. et al.; Illig, T.; Propping, P.; Holsboer, F.; Rietschel, M.; Nothen, M. M.: Supportive evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and depressive symptoms in affective disorder and schizophrenia. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 27 - 27 (2004)

Erhardt, A.; Kern, N.; Knorr, C. C.; Poluda, L.; Thoeringer, C. K.; Unschuld, G.; Salyakina, D.; Pütz, B.; Holsboer, F.; Binder, E. B. et al.; Müller-Myhsok, B.; Keck, M. E.: Possible association of oxytocin and prolactin polymorphisms with panic and anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 66 - 66 (2004)

Keck, M. E.; Kern, N.; Erhardt, A.; Ising, M.; Unschuld, P. G.; Knorr, C. C.; Poluda, L.; Thoeringer, C. K.; Salyakina, D.; Pütz, B. et al.; Holsboer, F.; Müller-Myhsok, B.; Binder, E.: Interactions of polymorphisms in corticotropin releasing hormone receptor 1 (CRHR1) and vasopressin receptor 1B (V1B) genes predispose for panic disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 64 - 65 (2004)

Kern, N.; Binder, E. B.; Pfennig, A.; Erhardt, A.; Ising, M.; Lucae, S.; Salyakina, D.; Pütz, B.; Holsboer, F.; Müller-Myhsok, B. et al.; Keck, M. E.: Possible association of angiotensin 1 converting enzyme polymorphisms with syndromal panic attacks. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 66 - 67 (2004)

Lucae, S.; Binder, E. B.; Pütz, B.; Salyakina, D.; Mueller-Myhsok, B.; Ising, M.; Horstmann, S.; Unschuld, P.; Holsboer, F.: Association of SNP within the serotonin transporter gene with depressive disorder and associated functional parameters. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 38 - 39 (2004)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Kern, N.; Lucae, S.; Horstmann, S.; Salyakina, D.; Pütz, B.; Binder, E. B.; Müller-Myhsok, B. et al.; Holsboer, F.; Keck, M. E.: Polymorphisms in serotonin receptor genes HTR1B, HTR2A, HTR2C and HTR4 are possibly associated with specific personality traits in patients suffering from anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 67 - 68 (2004)

Humphries, L. A.; Dangelmaier, C.; Sommer, K.; Kipp, K.; Kato, R. M.; Griffith, N.; Bakman, I.; Turk, C. W.; Daniel, J. L.; Rawlings, D. J.: Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase C gamma Src homology 2-Src homology 3 linker. Journal of Biological Chemistry 279 (36), S. 37651 - 37661 (2004)

Austin, C. P.; Battey, J. F.; Bradley, A.; Bucan, M.; Capecchi, M.; Collins, F. S.; Dove, W. F.; Duyk, G.; Dymecki, S.; Eppig, J. T. et al.; Grieder, F. B.; Heintz, N.; Hicks, G.; Insel, T. R.; Joyner, A.; Koller, B. H.; Lloyd, K. C. K.; Magnuson, T.; Moore, M. W.; Nagy, A.; Pollock, J. D.; Roses, A. D.; Sands, A. T.; Seed, B.; Skarnes, W. C.; Snoddy, J.; Soriano, P.; Stewart, D. J.; Stewart, F.; Stillman, B.; Varmus, H.; Varticovski, L.; Verma, I. M.; Vogt, T. F.; von Melchner, H.; Witkowski, J.; Woychik, R. P.; Wurst, W.; Yancopoulos, G. D.; Young, S. G.; Zambrowicz, B.: The knockout mouse project. Nature Genetics 36 (9), S. 921 - 924 (2004)

Cannich, A.; Wotjak, C. T.; Kamprath, K.; Hermann, H.; Lutz, B.; Marsicano, G.: CBI cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice. Learning & Memory 11 (5), S. 625 - 632 (2004)

Hatzinger, M.; Hemmeter, U. M.; Brand, S.; Ising, M.; Holsboer-Trachsler, E.: Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX/CRH-test response. Journal of Psychiatric Research 38 (5), S. 453 - 465 (2004)

Heim, S.; Hahn, K.; Sämann, P. G.; Fahrmeir, L.; Auer, D. P.: Assessing DTI data quality using bootstrap analysis. Magnetic Resonance in Medicine 52 (3), S. 582 - 589 (2004)

Himmerich, H.; Schuld, A.; Haack, M.; Kaufmann, C.; Pollmächer, T.: Early prediction of changes in weight during six weeks of treatment with antidepressants. Journal of Psychiatric Research 38 (5), S. 485 - 489 (2004)

Kalisch, R.; Salome, N.; Platzer, S.; Wigger, A.; Czisch, M.; Sommer, W.; Singewald, N.; Heilig, M.; Berthele, A.; Holsboer, F. et al.; Landgraf, R.; Auer, D. P.: High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats. NeuroImage 23 (1), S. 382 - 391 (2004)

Kuenzel, H. E.; Murck, H.; Held, K.; Ziegenbein, M.; Steiger, A.: Reboxetine induces similar sleep-EEG changes like SSRI's in patients with depression. Pharmacopsychiatry 37 (5), S. 193 - 195 (2004)

Müller, T.; Glass, J.; Müller, D.; Link, A.; Schenk, C.; Rammes, G.: A new galenic formulation of selegiline (Xilopae) in the treatment of Parkinson disease. Aktuelle Neurologie 31 (7), S. 347 - 352 (2004)

Murck, H.; Song, C.; Horrobin, D. F.; Uhr, M.: Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression. International Journal of Neuropsychopharmacology 7 (3), S. 341 - 349 (2004)